Of note, exogenous FGF-2 used alone has a moderate proliferative effect, suggesting that survival and proliferation of KIT-mutant GIST cells are not initially dependent on FGF-signaling, and this pathway becomes important in GIST only after KIT inhibition. The gene discussed is FGF2; the disease is gastrointestinal stromal tumor.